|
Volumn 20, Issue 2, 2000, Pages 1-15
|
Medication use evaluation: a work in progress.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CEFTRIAXONE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PROTON PUMP;
SEROTONIN ANTAGONIST;
TISSUE PLASMINOGEN ACTIVATOR;
ACCREDITATION;
ARTICLE;
COST BENEFIT ANALYSIS;
DRUG ANTAGONISM;
DRUG USE;
ECONOMICS;
HOSPITAL BED CAPACITY;
HUMAN;
ORGANIZATION AND MANAGEMENT;
PROFESSIONAL STANDARD;
TREATMENT OUTCOME;
UNITED STATES;
UNIVERSITY HOSPITAL;
CEFTRIAXONE;
COST-BENEFIT ANALYSIS;
CYCLOOXYGENASE INHIBITORS;
DRUG UTILIZATION REVIEW;
HOSPITAL BED CAPACITY, 500 AND OVER;
HOSPITALS, UNIVERSITY;
HUMANS;
IOWA;
JOINT COMMISSION ON ACCREDITATION OF HEALTHCARE ORGANIZATIONS;
PROFESSIONAL STAFF COMMITTEES;
PROTON PUMPS;
SEROTONIN ANTAGONISTS;
TISSUE PLASMINOGEN ACTIVATOR;
TREATMENT OUTCOME;
|
EID: 0034230892
PISSN: 10805737
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|